BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 15604239)

  • 1. Recombinant Listeria vaccines containing PEST sequences are potent immune adjuvants for the tumor-associated antigen human papillomavirus-16 E7.
    Sewell DA; Shahabi V; Gunn GR; Pan ZK; Dominiecki ME; Paterson Y
    Cancer Res; 2004 Dec; 64(24):8821-5. PubMed ID: 15604239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two Listeria monocytogenes vaccine vectors that express different molecular forms of human papilloma virus-16 (HPV-16) E7 induce qualitatively different T cell immunity that correlates with their ability to induce regression of established tumors immortalized by HPV-16.
    Gunn GR; Zubair A; Peters C; Pan ZK; Wu TC; Paterson Y
    J Immunol; 2001 Dec; 167(11):6471-9. PubMed ID: 11714814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ability of two Listeria monocytogenes vaccines targeting human papillomavirus-16 E7 to induce an antitumor response correlates with myeloid dendritic cell function.
    Peng X; Hussain SF; Paterson Y
    J Immunol; 2004 May; 172(10):6030-8. PubMed ID: 15128786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regression of established human papillomavirus type 16 (HPV-16) immortalized tumors in vivo by vaccinia viruses expressing different forms of HPV-16 E7 correlates with enhanced CD8(+) T-cell responses that home to the tumor site.
    Lamikanra A; Pan ZK; Isaacs SN; Wu TC; Paterson Y
    J Virol; 2001 Oct; 75(20):9654-64. PubMed ID: 11559797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant properties of listeriolysin O protein in a DNA vaccination strategy.
    Peng X; Treml J; Paterson Y
    Cancer Immunol Immunother; 2007 Jun; 56(6):797-806. PubMed ID: 17102978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fusion protein vaccine by domains of bacterial exotoxin linked with a tumor antigen generates potent immunologic responses and antitumor effects.
    Liao CW; Chen CA; Lee CN; Su YN; Chang MC; Syu MH; Hsieh CY; Cheng WF
    Cancer Res; 2005 Oct; 65(19):9089-98. PubMed ID: 16204084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A gold glyco-nanoparticle carrying a Listeriolysin O peptide and formulated with Advax™ delta inulin adjuvant induces robust T-cell protection against listeria infection.
    Rodriguez-Del Rio E; Marradi M; Calderon-Gonzalez R; Frande-Cabanes E; Penadés S; Petrovsky N; Alvarez-Dominguez C
    Vaccine; 2015 Mar; 33(12):1465-73. PubMed ID: 25659269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fusion to Listeriolysin O and delivery by Listeria monocytogenes enhances the immunogenicity of HER-2/neu and reveals subdominant epitopes in the FVB/N mouse.
    Singh R; Dominiecki ME; Jaffee EM; Paterson Y
    J Immunol; 2005 Sep; 175(6):3663-73. PubMed ID: 16148111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4+CD25+ regulatory T cells that secrete TGFbeta and IL-10 are preferentially induced by a vaccine vector.
    Hussain SF; Paterson Y
    J Immunother; 2004; 27(5):339-46. PubMed ID: 15314542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral vaccination with recombinant Listeria monocytogenes expressing human papillomavirus type 16 E7 can cause tumor growth in mice to regress.
    Lin CW; Lee JY; Tsao YP; Shen CP; Lai HC; Chen SL
    Int J Cancer; 2002 Dec; 102(6):629-37. PubMed ID: 12448006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Genetically Modified attenuated
    Jia YY; Tan WJ; Duan FF; Pan ZM; Chen X; Yin YL; Jiao XA
    Front Cell Infect Microbiol; 2017; 7():279. PubMed ID: 28706878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor sensitivity to IFN-gamma is required for successful antigen-specific immunotherapy of a transplantable mouse tumor model for HPV-transformed tumors.
    Dominiecki ME; Beatty GL; Pan ZK; Neeson P; Paterson Y
    Cancer Immunol Immunother; 2005 May; 54(5):477-88. PubMed ID: 15750832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Episomal expression of truncated listeriolysin O in LmddA-LLO-E7 vaccine enhances antitumor efficacy by preferentially inducing expansions of CD4+FoxP3- and CD8+ T cells.
    Chen Z; Ozbun L; Chong N; Wallecha A; Berzofsky JA; Khleif SN
    Cancer Immunol Res; 2014 Sep; 2(9):911-22. PubMed ID: 24872025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of two Listeria monocytogenes antigens (P60 and LLO) in Lactococcus lactis and examination for use as live vaccine vectors.
    Bahey-El-Din M; Casey PG; Griffin BT; Gahan CGM
    J Med Microbiol; 2010 Aug; 59(Pt 8):904-912. PubMed ID: 20488938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo bactofection: listeria can function as a DNA-cancer vaccine.
    Souders NC; Verch T; Paterson Y
    DNA Cell Biol; 2006 Mar; 25(3):142-51. PubMed ID: 16569193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose adenovirus vaccine encoding chimeric hepatitis B virus surface antigen-human papillomavirus type 16 E7 proteins induces enhanced E7-specific antibody and cytotoxic T-cell responses.
    Báez-Astúa A; Herráez-Hernández E; Garbi N; Pasolli HA; Juárez V; Zur Hausen H; Cid-Arregui A
    J Virol; 2005 Oct; 79(20):12807-17. PubMed ID: 16188983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic and therapeutic efficacy of an attenuated Listeria monocytogenes-based vaccine delivering HPV16 E7 in a mouse model.
    Jia Y; Yin Y; Duan F; Fu H; Hu M; Gao Y; Pan Z; Jiao X
    Int J Mol Med; 2012 Dec; 30(6):1335-42. PubMed ID: 23027427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant adeno-associated virus expressing human papillomavirus type 16 E7 peptide DNA fused with heat shock protein DNA as a potential vaccine for cervical cancer.
    Liu DW; Tsao YP; Kung JT; Ding YA; Sytwu HK; Xiao X; Chen SL
    J Virol; 2000 Mar; 74(6):2888-94. PubMed ID: 10684306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delivery of class I and class II MHC-restricted T-cell epitopes of listeriolysin of Listeria monocytogenes by attenuated Salmonella.
    Verma NK; Ziegler HK; Wilson M; Khan M; Safley S; Stocker BA; Schoolnik GK
    Vaccine; 1995 Feb; 13(2):142-50. PubMed ID: 7625107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological protection against HPV16 E7-expressing human esophageal cancer cell challenge by a novel HPV16-E6/E7 fusion protein based-vaccine in a Hu-PBL-SCID mouse model.
    Lu Y; Zhang Z; Liu Q; Liu B; Song X; Wang M; Zhao X; Zhao Q
    Biol Pharm Bull; 2007 Jan; 30(1):150-6. PubMed ID: 17202676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.